CPEC should not be politicised, says Sharif

May 14, 2017

Beijing, May 14: Pakistan Prime Minister Nawaz Sharif today said that the multi-billion dollar CPEC was an economic project open to all nations in the region and it "must not be politicised", taking pot-shots at India for boycotting China's high-profile Belt and Road Forum.

nawazIndia skipped the meeting due to its concerns over the China-Pakistan Economic Corridor (CPEC), which goes through Pakistan-occupied Kashmir (PoK). However, few Indian scholars attended the opening session of the two-day "Belt and Road" conference here that brought together leaders from 29 nations.

"Let me make it very clear that CPEC is an economic undertaking open to all countries in the region. It has no geographical boundaries. It must not be politicised," Sharif said in his speech at the inaugural session of the forum, defending the project over which India has raised objections.

Stating that CPEC has emerged as core and flagship project of China's One Belt and One Road (OBOR), he said, "OBOR signifies that geo-economics must take precedence over geo-politics and that the centre of gravity should shift from conflict to cooperation. We see it as a path for overcoming terrorism and extremism."

In implementing CPEC "we are not striving to merely leverage geography for economic prosperity, we are also trying to build peaceful, connected and caring neighbourhood," he told the gathering.

"It is time we transcend our differences, resolve conflicts through diplomacy and leave legacy of peace for future generations," Sharif said without directly referring to India.

Sharif, who is leading a large delegation and clinched more Chinese finance for six more projects of the CPEC, said "the fact is that OBOR belongs to all of us, those who are participating in it and those who are not as yet. OBOR has truly become a global community."

"As OBOR unfolds across continents we see it fostering inclusion, creating tolerance and promoting acceptance of cultural diversity," he said.

He said Pakistan believes that the most powerful impact of OBOR will be on the lives of poor and marginalised people who would have higher incomes, better education and health facilities. It would help eradicating poverty, he added.

"The CPEC is core project of OBOR. In fact it has been rightly called its flagship because it aims to connect neighbourhoods of East and West Asia. CPEC makes Pakistan both a conduit, destination for cross regional investment and trade," he said.

Terming China as Pakistan's "close friend and trusted ally", he said his participation at the forum was to celebrate the remarkable success of the seminal initiative of OBOR.

He also said that infrastructure, energy and industrial projects under CPEC are moving as envisaged.

Many of them would be completed before their timelines. Unprecedented economic social and cultural benefits will accrue from the CPEC not just for people of Pakistan but also the people of the entire region, he said.

"Through a resolute will and sound planning as well as steadfast support of our Chinese friends, we shaped an enabling environment for CPEC to take off," he said.

He said CPEC is also producing new entrepreneurs and creating new jobs and attracting international investment.

Playing down differences over the project among different provinces in his country, Sharif said, "the CPEC is owned and nurtured by all citizens of Pakistan. It is also fully compatible with our own vision 2025 which invests our own resources in multiple corridors of regional cooperation including energy, industry trade and transportation."

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 11,2020

Apr 11: The number of global coronavirus deaths has increased to 102,753, while the total number of cases worldwide has surpassed 1.6 million, according to the latest update by the Washington-based Johns Hopkins University.

As of Saturday morning, the overall number of infections increased to 1,698,416, while the tally of those who recovered from the deadly disease stood at 376,677, according to the varsity's Center for Systems Science and Engineering (CSSE).

In terms of cases, the US had the highest in the world at 501,301, followed by Spain 158,273, Italy 147,577 and France 125,931.

Italy accounted for the highest death toll at 18,849, with the US in the second place with 18,769 fatalities.

Other countries with more than 10,000 deaths include Spain (16,081) and France (13,197).

Although the pandemic originated in China last December, it now only accounts for 3,343 deaths with 83,003 confirmed cases.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 4,2020

Kuala Lumpur, Feb 4: Malaysia said on Tuesday that India's move to cut back on palm oil purchases is "temporary" and will be resolved amicably between the two nations.

Last month, India restricted imports of refined palm oil and asked importers to avoid purchases from Malaysia after its criticism of actions in Kashmir and a new citizenship law.

"Having long-standing bilateral ties, the two nations will overcome the current challenges, and prevail towards mutual and beneficial outcomes," the Malaysian Palm Oil Council said in a statement, citing Primary Industries Minister Teresa Kok.

Malaysia's push to implement B20 biodiesel starting this month will also help sustain high crude palm oil prices, the statement read.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.